FDA to Ban Common Decongestant Over Lack of Effectiveness

HEALTH News

FDA to Ban Common Decongestant Over Lack of Effectiveness
FDADecongestantPhenylephrine
  • 📰 NBCDFW
  • ⏱ Reading Time:
  • 68 sec. here
  • 8 min. at publisher
  • 📊 Quality Score:
  • News: 47%
  • Publisher: 63%

The FDA is phasing out phenylephrine, a common decongestant found in many over-the-counter medications, due to its lack of proven effectiveness in relieving nasal congestion.

U.S. officials are moving to phase out phenylephrine, the leading decongestant found in hundreds of over-the-counter medicines, because it doesn't actually relieve nasal congestion. Phenylephrine is used in popular versions of Sudafed, Dayquil and other medications, but experts have long questioned its effectiveness. Last month, the FDA formally proposed revoking its use in pills and liquid solutions, kicking off a process that's likely to force drugmakers to remove or reformulate products.

It’s a win for skeptical academics, including researchers at the University of Florida who petitioned the FDA to revisit the drug's use in 2007 and again in 2015. For consumers it will likely mean switching to alternatives, including an older decongestant that was moved behind the pharmacy counter nearly 20 years ago. Doctors say Americans will be better off without phenylephrine, which is often combined with other medicines to treat cold, flu, fever and allergies. “People walk into the drugstore today and see 55,000 medicines on the shelf and they pick one that is definitely not going to work,” said Dr. Brian Schroer of the Cleveland Clinic. “You take away that option and it will be easier for them to self-direct toward products that really will help them.” The FDA decision was expected after federal advisers last year voted unanimously that oral phenylephrine medications haven't been shown to relieve congestion. Experts reviewed several recent, large studies indicating that phenylephrine was no better than a placebo at clearing nasal passageways. They also revisited studies from the 1960s and 1970s that supported the drug’s initial use, finding numerous flaws and questionable data. The panel’s opinion only applied to phenylephrine in oral medications, which account for roughly $1.8 billion in annual U.S sales

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

NBCDFW /  🏆 288. in US

FDA Decongestant Phenylephrine Effectiveness Over-The-Counter Drugs

United States Latest News, United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

FDA Moves to Ban Common Decongestant, PhenylephrineFDA Moves to Ban Common Decongestant, PhenylephrineThe U.S. Food and Drug Administration (FDA) is phasing out phenylephrine, the leading decongestant found in hundreds of over-the-counter medications, due to a lack of effectiveness in relieving nasal congestion. This decision, based on decades of research and unanimous votes from FDA advisors, will likely force drugmakers to reformulate or remove products containing phenylephrine. Consumers may need to switch to alternative decongestants, potentially including those requiring a pharmacy prescription.
Read more »

FDA to Phase Out Common DecongestantFDA to Phase Out Common DecongestantThe FDA is taking action to remove phenylephrine, a common decongestant found in many over-the-counter medications, due to its lack of effectiveness in relieving nasal congestion.
Read more »

FDA to Phase Out Common Decongestant Found IneffectiveFDA to Phase Out Common Decongestant Found IneffectiveThe U.S. Food and Drug Administration is moving to phase out phenylephrine, the leading decongestant found in hundreds of over-the-counter medications, concluding that it doesn't actually relieve nasal congestion. This decision follows years of skepticism from experts and research indicating the drug's ineffectiveness. The FDA proposal is expected to force drugmakers to remove or reformulate products containing phenylephrine, prompting consumers to switch to alternative decongestants.
Read more »

FDA to Phase Out Common DecongestantFDA to Phase Out Common DecongestantThe FDA is taking action against phenylephrine, a common decongestant found in many over-the-counter medications, due to concerns about its effectiveness.
Read more »

FDA to Phase Out Common DecongestantFDA to Phase Out Common DecongestantThe FDA is phasing out phenylephrine, a common decongestant found in many over-the-counter medications, due to concerns about its effectiveness.
Read more »

US to Ban Common Decongestant Found IneffectiveUS to Ban Common Decongestant Found IneffectiveThe FDA is proposing to ban phenylephrine, a common decongestant found in many over-the-counter medications, after concluding it doesn't actually relieve nasal congestion.
Read more »



Render Time: 2025-02-19 16:42:03